Download new insights in head and neck squamous cell carcinoma (hnscc)

NEW INSIGHTS IN HEAD
AND NECK SQUAMOUS
CELL CARCINOMA (HNSCC)
You Are Invited
to a Breakfast Breakout Session at the Lurie Cancer Center
Multidisciplinary Head & Neck Symposium
7:00 to 7:45pm
Room Streeterville, Hyatt Chicago Magnificent Mile
633 North Saint Clair Street, Chicago, Illinois 60611
Presented by
Dr. Mark Kozloff
University of Chicago
Chicago, IL
Dr. Mark Kozloff will present
clinical trial data for a treatment
option in patients with recurrent
or metastatic head and neck
squamous cell carcinoma (HNSCC).
This presentation will provide a
brief overview of head and neck
cancer. Information will be discussed
including efficacy and safety data
while characterizing the clinical
profile of patients with recurrent
or metastatic HNSCC.
• Provide an overview of HNSCC
• Describe a treatment option for
recurrent or metastatic HNSCC
• Review data from a recent clinical
study in recurrent or metastatic
HNSCC
Seating is limited.
Please RSVP by December 1 to [email protected].
This event is for US licensed healthcare providers.
This optional non-CME educational activity is not approved for CME or continuing education credit. The content of this
optional non-CME activity and opinions expressed by presenters are those of the sponsor or presenters.
Copyright © 2016 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved. ONCO-1175881-0006 11/16